Anatomy and clinical importance of cholecystic venous drainage: helical CT observations during injection of contrast medium into the cholecystic artery.

Yoshimitsu, Kengo; Honda, Hiroshi; Kaneko, Koichiro; Kuroiwa, Toshiro; Irié, Hiroyuki; Chijiiwa, Kazuo; Takenaka, Katsuto; Masuda, Kouji

doi:10.2214/ajr.169.2.9242765

Cited by 89 publications

(72 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…GC dissemination is thought to be mainly locoregional, thus the majority of therapeutic schemes are designed to control this area. Locoregional recurrence occurs along the resection margin, in the porta hepatis and in the retroperitoneal lymph nodes and it likely arises from microscopic residual disease [7]. However, from our observations and from other reports, we have acknowledged the importance of distant metastases in the control of the disease.…”

Section: Introductionsupporting

confidence: 54%

Chemoradiotherapy in gallbladder cancer

Aretxabala

Roa

Berrios

et al. 2006

Journal of Surgical Oncology

View full text Add to dashboard Cite

Gallbladder cancer (GC) is considered a rare disease associated with a poor prognosis. Unfortunately, the low number of cases makes the performance of trials addressing the role of adjuvant, neoadjuvant, and/or palliative therapy difficult. For a long time, the majority of trials were 5-fluorouracil (5 FU)-based, and results were uniformly poor. Since the introduction of Gemcitabine, response rates of approximately 30% have been observed through the use of this drug and new approaches have been tested. In this sense, drugs such as Cisplatin and Capecitabine have been employed concurrently with gemcitabine and/or radiation. Since a recurrence pattern is both distant and local, chernoradiation seems a logical option to deal with the disease. However, at the present time, the lack of valid and scientific evidence means that most of the recommendations originate from trials dealing with other tumors, such as pancreas cancer and biliary tract cancer (BTC). The aforementioned treatment alternatives warrant further evaluation focusing on GC.

show abstract

Section: Introductionsupporting

confidence: 54%

Chemoradiotherapy in gallbladder cancer

Aretxabala

Roa

Berrios

et al. 2006

Journal of Surgical Oncology

View full text Add to dashboard Cite

show abstract

“…Karaciğerin büyük kısmı bu dual kan akımı ile beslenirken subkapsüller bazı alanlar başka bir venöz sistem (kolesistik, parabilier veya epigastrik-paraumbilikal) ile beslenir [3][4][5]. GHKF, karaciğerin hepatik arteryel, portal venöz ve hepatik kan akımının üçüncü giriş kaynaklarının arasındaki dengenin bölgesel farklılıklarının oluşturduğu görüntüleme bulgusudur.…”

Section: Discussionunclassified

Superior vena kava obstrüksiyonu olan iki hastada geçici hepatik kontrastlanma farklılığı: Bilgisayarlı tomografi bulguları

Başkan

Sahingoz

2015

Marmara Medical Journal

View full text Add to dashboard Cite

Ozdil BASKAN, Yusuf SAHİNGOZ ÖZET Karaciğerin kanlanmasındaki hemodinamiklerin bozulması sonucunda tümöral süreç ile karışan parankimal geçici kontrastlanma farklılıkları oluşabilir. Etiyolojide tümöral veya tümöral olmayan süreçler rol oynar. Superior vena kava obstrüksiyonları, geçici hepatik kontrastlanma farklılığı (GHKF) etiyolojileri arasında son derece nadir olarak karşımıza çıkar.Çalışmamızda, superior vena kava obstrüksiyonuna bağlı oluşan GHKF'nın bilgisayarlı tomografi bulguları sunulmuş ve tartışılmıştır. Anahtar kelimeler: Superior vena kava obstrüksiyonu, Karaciğer, Bilgisayarlı tomografi ABSTRACTRadiographic appearances of transient hepatic attenuation differences (THAD) can mimic tumors. THAD can occur as a result of altered hemodynamics of the hepatic blood flow. Tumoral or non-tumoral processes can play role in the etiology. THADs that appear secondary to the obstruction of the superior vena cava are rarely seen.Herein, we present computed tomography findings of two cases with THAD secondary to superior vena cava obstruction.

show abstract

“…Liver resection for GBC treatment ranges from partial hepatectomies (nonanatomical or anatomical resection of segments 4a and 5) to major extended hepatectomies. Anatomical resection of segments 4a and 5 is considered a good oncologic option for GBC because the cystic vein was found to drain into segment 4a (37-90%) and segment 5 (52-90%) [52,53]. A more aggressive approach consisting of routine right extended hepatectomy that includes the caudate lobe has been proposed.…”

Section: Updates In Gallbladder Diseasesmentioning

confidence: 99%

Incidental Gallbladder Cancer

Al-Alem¹,

Mattar²,

Madkhali³

et al. 2017

Updates in Gallbladder Diseases

View full text Add to dashboard Cite

Gallbladder cancer (GBC) is a rare but fatal disease with an incidence of less than 5000 new cases per year in the United States. Less than 20% of GBC cases are diagnosed preoperatively. The remaining cases are diagnosed either after laparoscopic cholecystectomy or intraoperatively. GBC is discovered incidentally during histopathology following 0.25-3.0% of laparoscopic cholecystectomies; however, this constitutes 74-92% of all GBC. The most pivotal and important step is accurate patient staging. Staging dictates disease management and treatment options and predicts survival. Because of the fatality of GBC and its poor prognosis, atempts of curative surgery are limited to localized resectable disease.

show abstract

Anatomy and clinical importance of cholecystic venous drainage: helical CT observations during injection of contrast medium into the cholecystic artery.

Cited by 89 publications

References 4 publications

Chemoradiotherapy in gallbladder cancer

Chemoradiotherapy in gallbladder cancer

Superior vena kava obstrüksiyonu olan iki hastada geçici hepatik kontrastlanma farklılığı: Bilgisayarlı tomografi bulguları

Incidental Gallbladder Cancer

Contact Info

Product

Resources

About